Research and development of protelytics from natural sources for the treatment of thrombotic states and chronic wounds (Q11201)

From EU Knowledge Graph
Revision as of 15:41, 22 October 2020 by DG Regio (talk | contribs) (‎Created claim: summary (P836): The subject of the project is the development of the process of preparation of highly effective proteolytics (KR-X) from Antarctic krill, which will be used in various fields of medicine. The output, in addition to technological procedures of preparation, will be two prototypes of KR-X proteolytic – for the treatment of chronic wounds and for thrombolysis of vascular thrombs. Due to the mechanism of action of the enzyme on undesirable fibrin and...)
Jump to navigation Jump to search
Project in Czech Republic financed by DG Regio
Language Label Description Also known as
English
Research and development of protelytics from natural sources for the treatment of thrombotic states and chronic wounds
Project in Czech Republic financed by DG Regio

    Statements

    0 references
    5,769,000.0 Czech koruna
    0 references
    230,760.0 Euro
    10 January 2020
    0 references
    15,384,000.0 Czech koruna
    0 references
    615,360.0 Euro
    10 January 2020
    0 references
    37.5 percent
    0 references
    12 May 2017
    0 references
    17 April 2020
    0 references
    VUAB Pharma a.s.
    0 references
    0 references

    50°9'46.91"N, 14°23'2.26"E
    0 references
    25263
    0 references
    Předmětem projektu je vývoj postupu přípravy vysoce účinných proteolytik (KR-X) z antarktického krillu, které budou použity v různých oborech medicíny. Výstupem, kromě technologických postupů přípravy, budou dva prototypy proteolytika KR-X - pro léčbu chronických ran a pro trombolýzu cévních trombů. Díky mechanismu působení enzymu na nežádoucí fibrin a fragmenty se předpokládá u pacientů lepší snášenlivost a nižší bolestivost léčby oproti agresívnějším enzymatickým prostředkům. a. (Czech)
    0 references
    The subject of the project is the development of the process of preparation of highly effective proteolytics (KR-X) from Antarctic krill, which will be used in various fields of medicine. The output, in addition to technological procedures of preparation, will be two prototypes of KR-X proteolytic – for the treatment of chronic wounds and for thrombolysis of vascular thrombs. Due to the mechanism of action of the enzyme on undesirable fibrin and fragments, patients are expected to be more tolerable and less painful than more aggressive enzymatic agents. a. (English)
    22 October 2020
    0 references

    Identifiers

    CZ.01.1.02/0.0/0.0/16_083/0010108
    0 references